Toyota|$17.53 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$21.51 (¥3,470)+0.93%▲ (in JPY terms)
SoftBank|$33.62 (¥5,424)-9.01%▼ (in JPY terms)
MUFG|$21.53 (¥3,473)-4.30%▼ (in JPY terms)
Keyence|$439.33 (¥70,880)-4.28%▼ (in JPY terms)
Nintendo|$45.21 (¥7,294)+3.02%▲ (in JPY terms)
NTT|$0.94 (¥151)+0.13%▲ (in JPY terms)
Takeda|$33.97 (¥5,480)+2.53%▲ (in JPY terms)
Tokyo Electron|$403.50 (¥65,100)-8.17%▼ (in JPY terms)
Recruit|$79.46 (¥12,820)+1.63%▲ (in JPY terms)
ITOCHU|$11.79 (¥1,903)-0.89%▼ (in JPY terms)
Honda|$9.52 (¥1,536)-1.48%▼ (in JPY terms)
Shin-Etsu|$44.36 (¥7,157)-2.77%▼ (in JPY terms)
Tokio Marine|$46.65 (¥7,526)-0.97%▼ (in JPY terms)
Fast Retailing|$488.67 (¥78,840)+0.00%▲ (in JPY terms)
Toyota|$17.53 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$21.51 (¥3,470)+0.93%▲ (in JPY terms)
SoftBank|$33.62 (¥5,424)-9.01%▼ (in JPY terms)
MUFG|$21.53 (¥3,473)-4.30%▼ (in JPY terms)
Keyence|$439.33 (¥70,880)-4.28%▼ (in JPY terms)
Nintendo|$45.21 (¥7,294)+3.02%▲ (in JPY terms)
NTT|$0.94 (¥151)+0.13%▲ (in JPY terms)
Takeda|$33.97 (¥5,480)+2.53%▲ (in JPY terms)
Tokyo Electron|$403.50 (¥65,100)-8.17%▼ (in JPY terms)
Recruit|$79.46 (¥12,820)+1.63%▲ (in JPY terms)
ITOCHU|$11.79 (¥1,903)-0.89%▼ (in JPY terms)
Honda|$9.52 (¥1,536)-1.48%▼ (in JPY terms)
Shin-Etsu|$44.36 (¥7,157)-2.77%▼ (in JPY terms)
Tokio Marine|$46.65 (¥7,526)-0.97%▼ (in JPY terms)
Fast Retailing|$488.67 (¥78,840)+0.00%▲ (in JPY terms)

JP3475350009

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revision of the product supply plan and revisions to the consolidated earnings forecast for the full fiscal year ending March 2026 will be displayed in a new window.”

by

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revis … 続きを読む

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab deruxtecan (T-DXd/DS-8201) for HER2-positive breast cancer following neoadjuvant therapy in the United States (242.9 KB) PDF file opens in a new window.”

by

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab d … 続きを読む

Contact